Markets › LSE › 0J2O.L

Halozyme Therapeutics, Inc.

LSE:0J2O.LHealthcare

——At close · Market cap — · Next earnings Mon 2 Nov

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.1	0.1	0.2	0.1	0.1	0.1	+15.5%
Cash & short-term investments	0.4	0.7	0.4	0.3	0.6	0.1	−76.0%
Receivables	0.1	0.1	0.2	0.2	0.3	0.4	+43.1%
Inventory	0.1	0.1	0.1	0.1	0.1	0.2	+24.4%
Total current assets	0.6	0.9	0.7	0.7	1.1	0.8	−24.0%
Property, plant & equipment	0.0	0.0	0.1	0.1	0.1	0.1	+9.5%
Goodwill & intangibles	0.0	0.0	1.0	0.9	0.8	1.6	+90.8%
Long-term investments	0.0	0.0	0.0	0.5	0.0	0.0	+62.6%
Total assets	0.6	1.1	1.8	1.7	2.2	2.7	+25.4%
Payables	0.0	0.0	0.0	0.0	0.0	0.0	+103.9%
Short-term debt	0.4	0.1	0.0	0.0	0.0	0.0	+59.9%
Total current liabilities	0.4	0.1	0.1	0.1	0.1	0.2	+27.3%
Long-term debt	0.0	0.8	1.5	1.5	1.5	2.2	+43.8%
Total debt	0.4	0.9	1.5	1.5	1.5	2.2	+43.2%
Net debt	0.2	0.8	1.3	1.4	1.4	2.1	+45.5%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	—
Total liabilities	0.4	0.9	1.7	1.6	1.8	2.7	+48.1%
Total equity	0.2	0.2	0.2	0.1	0.4	0.0	−86.6%
Retained earnings	(0.5)	(0.1)	0.1	0.1	0.4	0.1	−84.8%